Intra-Abdominal Ventriculoperitoneal Shunt Abscess from Streptococcus Pyogenes after Pharyngitis with Scarlet Fever: Case Report and Review of the Literature
DOI:
https://doi.org/10.17140/NOJ-1-107Keywords:
Abdominal abscess; Group A streptococcus; Shunt infection; Streptococcus pyogenes; Ventriculoperitoneal shunt.Abstract
Objective: Infection is one of the most frequent complications of ventriculoperitoneal shunts.
However, Streptococcus pyogenes (Group A Streptococcus, GAS) as a causative agent appears
to be extremely rare. We present an unusual case of a peritoneal shunt infection due to GAS that
occurred after pharyngitis with scarlet fever.
Case Description: A 31 year-old woman with congenital shunt-dependent hydrocephalus presented with fever, vomiting, and acute abdominal symptoms several weeks after being treated
for pharyngitis and scarlet fever. She was found to have a large intra-abdominal peritoneal
catheter-associated abscess that grew out GAS.
Results: The patient’s shunt was externalized at the clavicle and the cerebrospinal fluid (CSF)
was sterile. Her peritoneal abscess was treated by percutaneous drainage, laparotomy, and intravenous antibiotics. More permanent CSF diversion was accomplished via ventriculoatrial
shunt creation after treatment. She made a full recovery.
Conclusion: While shunt infection is an all too common clinical problem, this is the first report
of a peritoneal shunt infection caused by GAS after pharyngitis and scarlet fever. Presumably,
this infection occurred as a result of haematogenous spread to the shunt site in the abdomen.
References
McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sex-ton DJ. Risk factors for pediatric ventriculoperitoneal shunt in-fection and predictors of infectious pathogens. Clin Infect Dis. 2003; 36: 858-862. doi: 10.1086/368191
Stamos JK, Kaufman BA, Yogev R. Ventriculoperitoneal shunt infections with gram- negative bacteria. Neurosurgery.1993; 33: 858-862.
Rubin RC, GhatakNR, Visudhipan P. Asymptomatic perfo-rated viscus and gram- negative ventriculitis as a complica-tion of valve-regulated ventriculoperitoneal shunts. Report of two cases. J Neurosurg.1972; 37: 616-618. doi: 10.3171/ jns.1972.37.5.0616
Walker MJ, Barnett TC, McArthur JD, et al. Disease manifesta-tions and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev.2014; 27: 264-301. doi: 10.1128/CMR.00101-13
Patel C, Chaudhuri NR, Gaur S. Group A streptococcus ven-triculoperitoneal shunt infection in a child. Pediatr Infect Dis J.2012; 31: 660. doi: 10.1097/INF.0b013e31824c04a5
O’Brien KL, Beall B, Barrett NL, et al. Epidemiology of in-vasive group a streptococcus disease in the United States, 1995- 1999. Clin Infect Dis.2002; 35: 268-276. doi: 10.1086/341409
American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics. 1998; 101: 136-140.
Moskovitz M, Ehrenberg E, Grieco R, et al. Primary perito-nitis due to group A streptococcus. J Clin Gastroenterol. 2000; 30: 332-335.
Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis. 1990; 22: 421-429.
Schweinburg FB, Seligman AM, Fine J. Transmural migra-tion of intestinal bacteria; a study based on the use of radioac-tive Escherichia coli. N Engl J Med. 1950; 242: 747-751. doi: 10.1056/NEJM195005112421903
Chung JJ, Yu JS, Kim JH, Nam SJ, Kim MJ. Intraabdominal complications secondary to ventriculoperitoneal shunts: CT find-ings and review of the literature. AJR Am J Roentgenol. 2009; 193: 1311-1317. doi: 10.2214/AJR.09.2463
Popa F, Grigorean VT, Onose G, Popescu M, Strambu V, Sandu AM. Laparoscopic treatment of abdominal complications following ventriculoperitoneal shunt. J Med Life. 2009; 2: 426- 436.
Yang TK, Sim KB. Multiple liver abscesses associated with ventriculoperitoneal shunt infection: case report and review of the literature. J Korean Neurosurg Soc. 2013; 54: 441-443.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Neuro (NEURO) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.